Tumour Clinical Trial
Official title:
Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
In previous preclinical studies, our group found that Mirabegron, a clinical drug, could activate brown adipose tissue and inhibit tumor growth in tumour-bearing mice.Investigators look forward to further evaluating the effect of Mirabegron-mediated brown adipose tissue activation, so as to provide new drug applications for clinical cancer prevention and treatment
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02261415 -
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
|
Phase 3 | |
| Recruiting |
NCT06450145 -
Evaluate the Efficacy and Safety of Interferon-α Combined With ATO in the Treatment of Arsenic-resistant APL
|
N/A | |
| Active, not recruiting |
NCT05776732 -
Effect of CaviionTM Precaution Medical Adhesive-related Skin Injury in Tumor Patients With PICC Catherizaion
|
N/A | |
| Completed |
NCT01651182 -
Tranexamic Acid Versus Placebo for Blood to Reduce Perioperative Bleeding Post-liver Resection
|
Phase 3 | |
| Not yet recruiting |
NCT06205888 -
To Compare the Clinical Application of 18F-LNC1007 Injection PET/CT and 18F-FDG PET/CT
|
||
| Completed |
NCT03920371 -
Evaluation of a Prototype Hand Held Hybrid Gamma Camera
|
N/A | |
| Completed |
NCT03146624 -
Evaluation of Patients Satisfaction of Attachment Retained Versus Clasp Retained Obturators in Unilateral Total Maxillectomy
|
N/A |